PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Cash from Investing Activities (2021 - 2026)

PepGen (PEPG) posted Cash from Investing Activities of -$1.5 million for Q1 2026, up 97.8% sequentially from -$66.2 million in Q4 2025, and down 108.51% YoY from $17.1 million in Q1 2025.

Analysis

PepGen (PEPG) Cash from Investing Activities (2021 - 2026) Analysis & Trends

PepGen has reported Cash from Investing Activities for 6 years, with the latest figure at -$1.5 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 108.51% year-over-year to -$1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$33.8 million (down 266.78% YoY) and the FY2025 annual result came in at -$15.2 million, up 59.55% from the prior year.
  • Cash from Investing Activities grew to -$1.5 million in Q1 2026 per PEPG's latest filing, from -$66.2 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $26.5 million in Q4 2024 and troughed at -$66.2 million in Q4 2025.
  • A 5-year average of -$5.3 million and a median of -$1.0 million in 2023 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities sank 5127.35% in 2024, then surged 14312.78% in 2025.
  • Over 5 years, Cash from Investing Activities stood at -$1.1 million in 2022, then slumped by 2584.94% to -$29.6 million in 2023, then surged by 189.57% to $26.5 million in 2024, then slumped by 349.97% to -$66.2 million in 2025, then surged by 97.8% to -$1.5 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered -$1.5 million, -$66.2 million, and $18.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 PepGen 217.99 Mn 217.99 Mn - -3.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3.52 Mn
Mar 31, 2026 -1.46 Mn
Dec 31, 2025 -66.24 Mn
Sep 30, 2025 18.90 Mn
Jun 30, 2025 14.96 Mn
Mar 31, 2025 17.15 Mn
Dec 31, 2024 26.50 Mn
Sep 30, 2024 -133,000.00
Jun 30, 2024 -52.74 Mn
Mar 31, 2024 -11.29 Mn
Dec 31, 2023 -29.59 Mn
Sep 30, 2023 -225,000.00
Jun 30, 2023 -1.01 Mn
Mar 31, 2023 -1.18 Mn
Dec 31, 2022 -1.10 Mn
Sep 30, 2022 -430,000.00
Jun 30, 2022 -609,000.00
Mar 31, 2022 -1.61 Mn
Dec 31, 2021 -156,000.00
Sep 30, 2021 -24,000.00